| MiR-139 inhibits invasion and metastasis of colorectal cancer by targeting the type I insulin-like growth factor receptor K Shen, Q Liang, K Xu, D Cui, L Jiang, P Yin, Y Lu, Q Li, J Liu Biochemical pharmacology 84 (3), 320-330, 2012 | 171 | 2012 |
| Biological applications of copper-containing materials P Wang, Y Yuan, K Xu, H Zhong, Y Yang, S Jin, K Yang, X Qi Bioactive materials 6 (4), 916-927, 2021 | 150 | 2021 |
| MFN2 suppresses cancer progression through inhibition of mTORC2/Akt signaling K Xu, G Chen, X Li, X Wu, Z Chang, J Xu, Y Zhu, P Yin, X Liang, L Dong Scientific reports 7 (1), 41718, 2017 | 135 | 2017 |
| Hypoxia induces drug resistance in colorectal cancer through the HIF-1α/miR-338-5p/IL-6 feedback loop K Xu, Y Zhan, Z Yuan, Y Qiu, H Wang, G Fan, J Wang, W Li, Y Cao, ... Molecular Therapy 27 (10), 1810-1824, 2019 | 131 | 2019 |
| miR‐1915 inhibits Bcl‐2 to modulate multidrug resistance by increasing drug‐sensitivity in human colorectal carcinoma cells K Xu, X Liang, D Cui, Y Wu, W Shi, J Liu Molecular carcinogenesis 52 (1), 70-78, 2013 | 113 | 2013 |
| Cinobufacini inhibits colon cancer invasion and metastasis via suppressing Wnt/β-catenin signaling pathway and EMT J Wang, H Cai, Q Liu, Y Xia, LK Xing, Q Zuo, Y Zhang, C Chen, K Xu, ... The American journal of Chinese medicine 48 (03), 703-718, 2020 | 104 | 2020 |
| miR-297 modulates multidrug resistance in human colorectal carcinoma by down-regulating MRP-2 K Xu, X Liang, K Shen, D Cui, Y Zheng, J Xu, Z Fan, Y Qiu, Q Li, L Ni, J Liu Biochemical Journal 446 (2), 291-300, 2012 | 95 | 2012 |
| MiR-222 modulates multidrug resistance in human colorectal carcinoma by down-regulating ADAM-17 K Xu, X Liang, K Shen, L Sun, D Cui, Y Zhao, J Tian, L Ni, J Liu Experimental cell research 318 (17), 2168-2177, 2012 | 89 | 2012 |
| A novel anoikis-related gene signature predicts prognosis in patients with head and neck squamous cell carcinoma and reveals immune infiltration H Chi, P Jiang, K Xu, Y Zhao, B Song, G Peng, B He, X Liu, Z Xia, G Tian Frontiers in Genetics 13, 984273, 2022 | 82 | 2022 |
| Photodynamic therapy synergizes with PD-L1 checkpoint blockade for immunotherapy of CRC by multifunctional nanoparticles Z Yuan, G Fan, H Wu, C Liu, Y Zhan, Y Qiu, C Shou, F Gao, J Zhang, ... Molecular Therapy 29 (10), 2931-2948, 2021 | 75 | 2021 |
| SHCBP1 is over-expressed in breast cancer and is important in the proliferation and apoptosis of the human malignant breast cancer cell line W Feng, H Li, K Xu, Y Chen, L Pan, Y Mei, H Cai, Y Jiang, T Chen, D Feng Gene 587 (1), 91-97, 2016 | 75 | 2016 |
| Exosome-based bone-targeting drug delivery alleviates impaired osteoblastic bone formation and bone loss in inflammatory bowel diseases J Guo, F Wang, Y Hu, Y Luo, Y Wei, K Xu, H Zhang, H Liu, L Bo, S Lv, ... Cell Reports Medicine 4 (1), 2023 | 72 | 2023 |
| T-cell exhaustion signatures characterize the immune landscape and predict HCC prognosis via integrating single-cell RNA-seq and bulk RNA-sequencing H Chi, S Zhao, J Yang, X Gao, G Peng, J Zhang, X Xie, G Song, K Xu, ... Frontiers in immunology 14, 1137025, 2023 | 66 | 2023 |
| β-sitosterol reverses multidrug resistance via BCRP suppression by inhibiting the p53–MDM2 interaction in colorectal cancer Z Wang, Y Zhan, J Xu, Y Wang, M Sun, J Chen, T Liang, L Wu, K Xu Journal of agricultural and food chemistry 68 (12), 3850-3858, 2020 | 62 | 2020 |
| Cantharidin inhibits the growth of triple-negative breast cancer cells by suppressing autophagy and inducing apoptosis in vitro and in vivo H Li, Z Xia, Y Chen, F Yang, W Feng, H Cai, Y Mei, Y Jiang, K Xu, D Feng Cellular Physiology and Biochemistry 43 (5), 1829-1840, 2018 | 62 | 2018 |
| Targeting Mcl-1 enhances DNA replication stress sensitivity to cancer therapy G Chen, AT Magis, K Xu, D Park, SY David, TK Owonikoko, GL Sica, ... The Journal of clinical investigation 128 (1), 500-516, 2018 | 59 | 2018 |
| Reversal of P-gp-mediated multidrug resistance in colon cancer by cinobufagin Z Yuan, X Shi, Y Qiu, T Jia, X Yuan, Y Zou, C Liu, H Yu, Y Yuan, X He, ... Oncology Reports 37 (3), 1815-1825, 2017 | 58 | 2017 |
| Identification and validation of neurotrophic factor-related gene signatures in glioblastoma and Parkinson’s disease S Zhao, H Chi, Q Yang, S Chen, C Wu, G Lai, K Xu, K Su, H Luo, G Peng, ... Frontiers in immunology 14, 1090040, 2023 | 57 | 2023 |
| miR-503-5p confers drug resistance by targeting PUMA in colorectal carcinoma K Xu, G Chen, Y Qiu, Z Yuan, H Li, X Yuan, J Sun, J Xu, X Liang, P Yin Oncotarget 8 (13), 21719, 2017 | 56 | 2017 |
| Engineered extracellular vesicles for bone therapy Y Jiang, J Li, X Xue, Z Yin, K Xu, J Su Nano Today 44, 101487, 2022 | 52 | 2022 |
